Latest Insider Transactions at Verona Pharma PLC (VRNA)
This section provides a real-time view of insider transactions for Verona Pharma PLC (VRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Verona Pharma plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Verona Pharma plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
413,168
-2.45%
|
$826,336
$2.56 P/Share
|
|
Jan 20
2023
|
Claire Poll General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
178,800
+7.48%
|
-
|
|
Jan 20
2023
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,000
+3.18%
|
-
|
|
Dec 23
2022
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
2,170,368
-2.03%
|
$49,918,464
$23.2 P/Share
|
|
Dec 23
2022
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
2,170,368
-2.03%
|
$49,918,464
$23.2 P/Share
|
|
Dec 22
2022
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Indirect |
240,000
-23.66%
|
$480,000
$2.69 P/Share
|
|
Dec 22
2022
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
3,969,496
-5.01%
|
$83,359,416
$21.89 P/Share
|
|
Dec 22
2022
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
3,969,496
-5.01%
|
$83,359,416
$21.89 P/Share
|
|
Dec 20
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600,000
-3.44%
|
$1,200,000
$2.12 P/Share
|
|
Dec 20
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-3.27%
|
$1,200,000
$2.12 P/Share
|
|
Nov 22
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
170,000
+14.36%
|
-
|
|
Nov 22
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
170,000
-7.72%
|
-
|
|
Nov 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,160
-0.08%
|
$13,160
$1.67 P/Share
|
|
Nov 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
454,856
-2.54%
|
$454,856
$1.6 P/Share
|
|
Nov 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-0.92%
|
$28,752
$1.64 P/Share
|
|
Nov 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,264
-1.77%
|
$56,264
$1.6 P/Share
|
|
Nov 01
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
32,904
-0.18%
|
$32,904
$1.67 P/Share
|
|
Nov 01
2022
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,856
-2.41%
|
$454,856
$1.6 P/Share
|
|
Sep 26
2022
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,600,000
+16.03%
|
-
|
|
Sep 26
2022
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,600,000
+16.73%
|
-
|
|
Sep 26
2022
|
Claire Poll General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+23.79%
|
-
|
|
Sep 26
2022
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+20.12%
|
-
|
|
Aug 21
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
90,104
+9.64%
|
-
|
|
Aug 21
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
90,104
-3.93%
|
-
|
|
Aug 15
2022
|
Access Industries Holdings LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,800,000
+7.91%
|
$4,800,000
$1.31 P/Share
|
|
Aug 09
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-3.78%
|
$600,000
$1.75 P/Share
|
|
Aug 09
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600,000
-4.02%
|
$600,000
$1.75 P/Share
|
|
Aug 02
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-1.2%
|
$0
$0.7 P/Share
|
|
Aug 01
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
32,904
-0.21%
|
$0
$0.7 P/Share
|
|
Aug 01
2022
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,864
-2.78%
|
$0
$0.67 P/Share
|
|
Aug 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,432
-2.29%
|
$0
$0.67 P/Share
|
|
Aug 01
2022
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
79,896
-4.34%
|
$0
$0.67 P/Share
|
|
Aug 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,168
-0.09%
|
$0
$0.7 P/Share
|
|
Aug 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
454,856
-2.96%
|
$0
$0.67 P/Share
|
|
May 22
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
90,104
+10.67%
|
-
|
|
May 22
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
90,104
-3.78%
|
-
|
|
May 03
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,512
-0.08%
|
$0
$0.5 P/Share
|
|
May 03
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-1.15%
|
$0
$0.49 P/Share
|
|
May 03
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
32,904
-0.2%
|
$0
$0.5 P/Share
|
|
May 01
2022
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,864
-2.7%
|
$0
$0.52 P/Share
|
|
May 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
432,128
-2.73%
|
$0
$0.52 P/Share
|
|
May 01
2022
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
79,896
-4.16%
|
$0
$0.52 P/Share
|
|
May 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,432
-2.22%
|
$0
$0.52 P/Share
|
|
Apr 11
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
59,720
-2.29%
|
$0
$0.54 P/Share
|
|
Apr 08
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
112,800
-4.15%
|
$0
$0.59 P/Share
|
|
Feb 22
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
90,104
+11.95%
|
-
|
|
Feb 22
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
90,104
-3.64%
|
-
|
|
Feb 03
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
52,056
-0.31%
|
$0
$0.73 P/Share
|
|
Feb 02
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,416
-0.07%
|
$0
$0.76 P/Share
|
|
Feb 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
288,320
-1.79%
|
$0
$0.78 P/Share
|